DPP-4 inhibitors Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: Vendor-neutral scientific reference catalog classification of the DPP-4 inhibitor pharmacologic class.

Antidiabetic agents; incretin-based drugs; pharmacologic class compound Reference needs_revision Best effort · source review pending

Also known as: Dipeptidyl peptidase-4 inhibitors, Dipeptidyl peptidase IV inhibitors, DPP-IV inhibitors, Gliptins

Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.

Quick Facts

Reference Sizes
Not standardized / source review pending
Components
Alogliptin + Linagliptin + Saxagliptin + Sitagliptin

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component
Alogliptin
Calculator Profile
Component
Linagliptin
Calculator Profile
Component
Saxagliptin
Calculator Profile
Component
Sitagliptin
Calculator Profile
Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Best-Effort Research Profile

DPP-4 inhibitors, also called gliptins, inhibit the enzymatic activity of dipeptidyl peptidase-4 (DPP-4/CD26). This reduces degradation of active GLP-1 and GIP, thereby supporting glucose-dependent insulin secretion and suppressing glucagon secretion. The class includes chemically distinct agents with differing pharmacokinetic properties; it is not a single chemical entity.

Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.

Research Profile

Administration Routes (Research)
Oral

Reported Research Effects

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Notes

Evidence-backed dosing, half-life, onset, solubility, storage, and formulation information is member-specific and should not be generalized across the class. Common reference sizes are not an appropriate class-level scientific catalog attribute.

Supplementary research context only. Not medical advice or a treatment recommendation.

Registry Identifiers

No single CAS number, UNII, molecular formula, SMILES, or other small-molecule identifier applies to the class as a whole.

Source-Backed Observations

This record represents a pharmacologic class rather than one discrete compound. Member-specific identity, molecular, pharmacokinetic, formulation, storage, and administration details should be recorded separately for each inhibitor.

Reflects published research. Educational reference — not a recommendation for use.

Sources Under Review

Dipeptidyl Peptidase IV (DPP IV) Inhibitors
https://www.ncbi.nlm.nih.gov/books/NBK542331/?report=classic (accessed 2026-09-13)
Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)
https://pubmed.ncbi.nlm.nih.gov/19748065/ (accessed 2026-09-13)
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
https://pmc.ncbi.nlm.nih.gov/articles/PMC7108477/ (accessed 2026-09-13)

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention DPP-4 inhibitors or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top